| Name
|
[DPhe12, Nle21,38, Glu30, Lys33] Corticotropin Releasing Factor (12-41), human, rat
|
| Code
|
|
| The alias
|
[DPhe12, Nle21,38, Glu30, Lys33] Corticotropin Releasing Factor (12-41), human, rat
|
| Sequence (single letter abbreviation)
|
DPhe-HLLREVLE-Nle-ARAEQLAQEAHKNRKL-Nle-EII-NH2
|
| Sequence (three-letter abbreviation)
|
DPhe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Glu-Ala-His-Lys-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2(trifluoroacetate salt)
|
| A basic description
|
A new CRF antagonist (cyclo(30/33) that, when injected into the CSF at low doses (1-10ug), results in antagonistic action against CRF and stress-related alterations of gastrointestinal motor function, without an intrinsic effect in these in vivo systems.
|
| solubility
|
|
| The molecular weight
|
3581.3
|
| Chemical formula
|
C161H271N49O43
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
|